| Returns | 1W : 0.2% , 1M : -4%,1Y : 95.1% |
| Peers & Returns | 1W | 1M | 1Y |
| GUJARAT THEMIS BIOSYN LTD | 0.2% | -4% | 95.1% |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 0% | 3% | 58.9% |
| DR REDDYS LABORATORIES LTD | -0.8% | -3.2% | 43.9% |
| DIVIS LABORATORIES LTD | 0.4% | 2.7% | 57.2% |
| CIPLA LTD | -0.2% | -4.4% | 86.2% |
| BIOCON LTD | 2.6% | 6.3% | 30.6% |
| AUROBINDO PHARMA LTD | 2% | -3.6% | 67.6% |
| LUPIN LTD | 1.2% | 1.5% | 52.2% |
| TORRENT PHARMACEUTICALS LTD | 0.5% | -6.4% | 8% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
13.98
P/E Calculated based on EPS of 16.3
[ Mar2020 - Standalone Results ] 7.85
P/B Calculated based on Book Value of 29.04
[ Mar2020 - Standalone Results ] 3.71
P/S Calculated based on Revenues of 89.079 Cr
[ TTM - Standalone Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
NA 364% 376% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
